Cartography Biosciences
Agent39Agent Readiness: 39/100. Below median. Measured by StartupHub.ai. Median 41.Trust92Data Trust: 92/100. Top 25%. Measured by StartupHub.ai. Median 61.A biotechnology company focused on oncology drug discovery.
About this profileCompany details: from public sourcesFunding: no announced round on fileOwnership: not yet claimed by the companyScores: measured by named tools; each links to its methodOur rules
About
Cartography Biosciences is a science pipeline platform company developing cancer immunotherapies. They identify and profile antigens at unprecedented scale using single-cell genomics and proteomics to create a comprehensive antigen atlas, enabling the discovery of safer and more effective drug targets. This approach aims to widen the world of treatable cancers by creating precise, broad, and safe therapeutics for patients.
Similar companies
Biotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.
Shares Biotechnology, Drug Discovery
Nimbus Therapeutics is a clinical-stage biotech company using computational drug discovery to develop small molecule medicines.
Shares Biotechnology, Drug Discovery
Developing novel Alphamer® therapeutics to combat serious diseases, with a primary focus on antimicrobial resistance (AMR).
Shares Biotechnology, Pharmaceuticals
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Shares Biotechnology, Pharmaceuticals
A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
Shares Biotechnology, HealthTech
Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
Shares Biotechnology, Pharmaceuticals
Key facts
- Website
- cartography.bio
- Headquarters
- South San Francisco, California, USA
- Founded
- 2021
- Total funding
- $150M (Strategic Investment)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 6 May 2026 | Strategic Investment | Undisclosed | |
| 28 Jun 2023 | Series B | $100M | Arch Venture Partners |
| 1 Nov 2021 | Seed | $50M | Arch Venture Partners |
Tech stack
Detected on cartography.bio, last scanned 3 Nov 2026. Run your own scan
- Frontend
- jQuery
- SEO
- Yoast SEO
- CMS / Builders
- WordPress
- CDN
- Cloudflare
- Email provider
- Barracuda
Cartography Biosciences scores 20. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
Is Cartography Biosciences trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Cartography Biosciences is 92 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Cartography Biosciences raised?
Cartography Biosciences has raised a total of $150M in funding. The most recent round on record is Strategic Investment.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Cartography Biosciences
